ARCHIVES

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License

November 10, 1995

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

ASCO Foundation Renamed

February 18, 2011

CCI Gets Qualified Approval To Continue

January 18, 1980

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001